Q3 2023 13F Holders as of 30 Sep 2023
-
Type / Class
-
Equity / COM
-
Shares outstanding
-
66,399,673
-
Total 13F shares
-
68,143,293
-
Share change
-
+1,629,564
-
Total reported value
-
$1,562,080,097
-
Put/Call ratio
-
22%
-
Price per share
-
$22.92
-
Number of holders
-
143
-
Value change
-
+$52,384,052
-
Number of buys
-
84
-
Number of sells
-
52
Institutional Holders of RHYTHM PHARMACEUTICALS, INC. - COM (RYTM) as of Q3 2023
As of 30 Sep 2023 RHYTHM PHARMACEUTICALS, INC. - COM (RYTM) had 143 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 68,143,293 shares of stock of the company.
Largest 10 holders included PRIMECAP MANAGEMENT CO/CA/, BAKER BROS. ADVISORS LP, BlackRock Inc., RA CAPITAL MANAGEMENT, L.P., GOLDMAN SACHS GROUP INC, VANGUARD GROUP INC, NEA Management Company, LLC, Polar Capital Holdings Plc, Frazier Life Sciences Management, L.P., and STATE STREET CORP.
This table shows 143 institutional shareholders of the security as of 30 Sep 2023.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.